MK-8808

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Follicular LymphomaRheumatoid Arthritis

Phase 1

Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

TerminatedNCT01370694

Merck Sharp & Dohme LLCFollicular Lymphoma

Start: 2011-08-19End: 2014-12-01Updated: 2019-03-15

A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)

TerminatedNCT01390441

Merck Sharp & Dohme LLCRheumatoid Arthritis

Start: 2011-07-31End: 2014-04-30Updated: 2016-07-20